Chapter 40: Gastric and Intestinal Disorders

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Imagine a complex, continuous chemical processing plant.

It takes in raw materials, extracts the exact nutrients it needs,

neutralizes toxins,

and precisely manages waste,

all while operating completely autonomously.

Right, it's an absolute marvel of engineering.

Exactly, until like a single pressure valve gets slightly loose or maybe the internal sensors misfire.

And suddenly the new coastal lining is just fighting itself.

Yeah, that perfectly engineered plant is suddenly compromised.

Welcome to the deep dive.

Today we are looking at the ultimate chemical processing plant, which is the human GI tract.

And you know, for those of you heading into advanced clinical practice, those seemingly minor malfunctions can cascade from like a mild annoyance straight into a life threatening emergency.

Which is why our mission today is highly specific.

We're skipping the basic anatomy.

Instead, we are partnering with the Last Minute Lecture team to give you a comprehensive one -on -one study session on gastric and intestinal disorders.

We're pulling directly from your core advanced practice nursing The goal is to connect the dots from foundational pathophysiology straight to assessment, clinical reasoning,

and patient -centered management.

So grab your mental notepad.

Yeah, we are going to move systematically, right?

Starting at the very top of the GI tract, working our way down, visualizing this spatial journey is going to make it much easier to anchor these clinical concepts in your mind.

Okay, so starting at the top, this is where acid inappropriately escapes the stomach and damages the esophageal mucosa.

We're talking about gastroesophageal reflux disease,

or GERD.

Right, GERD.

We all know the lower esophageal sphincter, the LES, it acts as a, well, a one -way plumbing valve.

You swallow, it opens, it snaps shut.

But in GERE, the resting pressure of that valve just drops.

It does.

Normal baseline LES pressure sits between like 10 to 30 millimeters of mercury.

In severe GERD, it drops below 10.

Wow, below 10.

Yeah, the valve literally gets leaky.

And the critical factor here isn't just that gastric acid, which, keep in mind, has a pH of less than 3 .9 splashes up.

It's the duration of that exposure.

Right, because gravity isn't helping when they're asleep.

Exactly.

When a patient lies down, gravity can't clear the esophagus, so that highly acidic fluid just pools and sits right on the esophageal mucosa.

Which basically forces the tissue to adapt just to survive.

But, I mean, this is one of those times where the body's adaptation is actually incredibly dangerous, right?

It's extremely dangerous.

The constant chemical burn destroys the normal guamus epithelium.

And as it heals, the body replaces it with metaplastic columnar epithelium.

That's Barrett's epithelium.

Exactly, Barrett's.

It survives the acid much better, but there's a massive trade -off because it is highly pre -malignant.

Having Barrett's esophagus confers a 40 -fold increased risk for developing esophageal adenocarcinoma.

40 -fold.

Okay, so that is a vital screening point for you guys to remember.

And when we talk about managing GRE, treating it feels a bit like

looking at an iceberg.

I like that analogy.

Yeah, at the surface, poking out of the water, you've got the lifestyle fixes for the mild cases, elevating the head of the bed, avoiding meals three hours before sleep, cutting out triggers like peppermint, chocolate, alcohol.

And there's a physiological reason for that, too.

Things like peppermint actively relax smooth muscle, which just further drops that LES pressure.

Right.

But beneath the surface, for the moderate to severe cases, that's where the heavy pharmacological management lies.

Right.

And the standard of care there is an eight -week trial of proton pump inhibitors, or PPIs.

But here is where you really need to educate your patients because the timing of the dose is everything.

Timing is everything, yeah.

Traditional PPIs must be taken 30 to 60 minutes before breakfast.

See why that specific window?

Because I feel like I see patients taking them right for bed all the time.

And that is exactly why their therapy fails.

PPIs are pro drugs.

They require an acidic environment in the parietal cell canalculi just to become active.

And they only bind to proton pumps that are actively secreting acid.

Oh, I see.

Yeah.

So fasting overnight builds up the highest number of resting pumps.

Taking the PPI 30 minutes before breakfast ensures that right when the meal stimulates all those pumps to turn on thumb.

The drug concentration in the blood is at its peak to just shut them down.

Exactly.

That is a brilliant mechanical detail.

Okay, so if they fail that eight -week PPI trial, or if they show up with dysphagia, GI bleeding, or unexplained weight loss, that pushes us straight to an EGD to directly visualize what's going on.

Yes, those are clear indications for a scope.

But let's pause and look at clinical reasoning for a second.

If a patient comes in with a burning stomach, my first thought is G or D.

But heptic ulcer disease, PUD,

it presents with almost identical upper GI pain.

Am I just guessing until I get them down for an EGD?

You're definitely not guessing.

You're looking for the clinical hallmark, which is how the pain responds to food.

Okay, unpack that.

So in GRD, the burning usually worsens shortly after eating, regardless of what the meal is.

But in PRD, the specific location of the ulcer completely changes the timing.

If it's a duodenal ulcer, the pain is actually relieved by eating.

The food acts as a physical buffer as it enters the duodenum.

Okay, and if it's a gastric ulcer?

Conversely, eating makes the pain significantly worse.

The physical presence of food stimulates immediate acid secretion right onto the ulcer bed.

Okay, so food buffers the duodenal ulcer but triggers the gastric one.

That makes perfect sense.

And when we do confirm PUD, we're essentially hunting two main culprits, right?

Chronic NSAID -Zoo or NH pylori infection.

Exactly.

With NSAIDs, the mechanism is straight chemical sabotage.

They inhibit cycloxanase, which drops prostaglandin synthesis.

And without prostaglandins, the stomach just stops secreting its protective mucus and bicarbonate shield.

Leaving it totally vulnerable, but if we suspect H.

pylori, how are we confirming that?

Well, there are four main tests you need to know.

A fecal antigen assay, a urea breath test, serology, and a biopsy via EGD.

Serology isn't super helpful though, right?

It's the least helpful because it can't distinguish between an active infection or just a past one.

The urea breath test is fascinating though.

How does that work?

Well, H.

pylori survives the stomach acid by secreting urease, which is an enzyme that breaks down urea into ammonia and carbon dioxide.

So we literally have the patient swallow a pill with tagged carbon urea.

If H.

pylori is present, it breaks it down and we can actually measure the tagged CO2 that the patient exhales.

That is incredibly clever engineering.

So once we confirm H.

pylori,

the eradication protocol is pretty aggressive.

We're usually looking at a 14 -day standard bismuth quadruple therapy.

Yeah, that's a PPI, bismuth, tetracycline, and metronidazole.

Why so many at once?

The reason we throw so much at it is that H.

pylori develops resistance very rapidly.

Bismuth is a great cornerstone here because it physically coats the ulcer, but it also has direct antimicrobial action.

It actually disrupts the bacterial cell wall.

Oh, wow.

And a quick clinical pro tip here.

Remember to warn your patients that bismuth reacts with sulfur in the GI tract to form bismuth sulfide, which turns their stool pitch black.

It is completely harmless, but if you don't warn them, you'll definitely be getting some panic phone calls.

Absolutely.

You have to prep them for that.

So we've covered the chemical damage in the upper GI tract.

Let's move down to structural failures.

The physical mechanical pressure issues.

We'll start the anorectal base with hemorrhoids, and then move to the abdominal wall for hernias.

Sounds good.

So hemorrhoids are essentially prolapsed sub -eucosal tissue containing dilated veins, and we classify them purely by anatomy.

Internal versus external.

Right.

External hemorrhoids arise from the inferior venous plexus, which is below the dentate line.

They're covered by anoderm, which is highly innervated, meaning they are exquisitely painful, especially if they thrombose.

Ouch.

And internal.

Internal hemorrhoids originate from the superior plexus above the dentate line.

They aren't as painful, but they tend to bleed, usually presenting as like bright red blood on the toilet paper.

And in the clinic, we grade those internal hemorrhoids on a scale of one to four, right?

Grade I means they bulge into the canal, but don't protrude out.

Grade II protrudes during a bowel movement, but snaps back on its own.

Then grade III protrudes and requires the patient to manually push it back in.

And grade III is just permanently stuck outside.

And that grading perfectly dictates your management.

It's a step -up approach.

For early grades, we focus on decreasing the mechanical pressure.

So 30 to 35 grams of dietary fiber daily, aggressive hydration, and sitz baths.

And if they fail that?

If they hit grade VII or III and fail conservative measures, you're looking at rubber band logation to cut off the blood supply to the prolapsed tissue.

By grade III, they usually need a surgical hemorrhidectomy.

Okay, let's move from the anorectal base to the abdominal wall.

Hernias.

I always picture an abdominal hernia kind of like a bicycle tire.

Oh, that's a good way to look at it.

Yeah, like if the thick outer rubber tire gets a tear in it, the moment you inflate the inner tube, it bulges right through that weak spot.

In the body, the inner tube is the peritoneal sac or the bowel, and the tire is the abdominal musculature.

That's a great visualization.

A groin hernia happens when the body's natural pressure containment systems fail.

Normally, you have this shutter mechanism where the internal oblique and transversus abdominis muscles tightly overlap when you cough or strain.

Right, to hold everything in.

Exactly.

You also have a sinker mechanism constricting the deep inguinal ring.

When those mechanisms fail, the bowel just pushes right through.

And we usually see two main types of inguinal hernias, indirect and direct.

Right.

Indirect hernias push through the internal inguinal ring.

This is often a congenital weakness, and we see it more frequently in younger males.

Whereas direct hernias push straight through a weak point in the posterior wall of the inguinal canal called Hesselbach's triangle.

We see these more in men over 40 as that tissue weakens over time.

But your priority as an advanced practice nurse isn't just diagnosing the type.

It's assessing the immediate threat to life.

The red flags.

Exactly.

An easily reducible hernia one you can gently push back in that can be managed electively.

But if a hernia becomes incarcerated, it means it's trapped and causing a bowel obstruction.

And if it progresses from incarcerated to strangulated.

That is the ultimate red flag.

That means the physical constriction is so tight it is completely cut off arterial blood flow to that section of bowel.

Ischemia sets in within hours, followed by necrosis and perforation.

Wow.

Both incarcerated and strangulated hernias demand immediate surgical referral.

Absolutely.

Okay, so we've been talking about clear structural failures.

Walls tearing,

veins bulging.

But what happens when the anatomy looks completely perfect on a CT scan?

The scope shows healthy pink tissue.

But the patient is still in agonizing abdominal pain.

That brings us to functional disorders and autoimmune destruction.

Specifically IBS and celiac disease.

Let's start with irritable bowel syndrome or IBS.

Because I feel like there's this lingering stigma that IBS is just a catch -all term for we don't know what's wrong.

There is, but it's completely false.

It's actually a highly specific functional disorder of gut -brain interaction.

The enteric nervous system is essentially misfiring.

We diagnose it using the strict Rome IV criteria.

Right.

Which requires recurrent abdominal pain at least one day a week for the past three months.

And that pain must be associated with two things.

Tell them what they are.

Either it's directly related to defecation, or there's a distinct change in how often they stool, or change in the physical form of the stool.

Crucially though, this is a diagnosis of exclusion regarding organic disease.

IBS should never present with alarm signs.

Like what?

If your patient mentions bloody stools, unintended weight loss, nocturnal diarrhea that literally wakes them up from sleep, or if you see anemia or leukocytosis on their labs that is not IBS, you must look deeper.

Got it.

And management is totally tailored to whether they have IBS with constipation, diarrhea, or a mixed pattern.

But generally, the low FODME diet is a heavy hitter here.

Very much so.

Because FODMEs are short -chain carbohydrates that are poorly absorbed, right?

They pull water into the bowel via osmosis, and are rapidly fermented by gut bacteria, causing massive gas and distension.

Cutting them out reduces that mechanical stretch that triggers those hypersensitive nerves.

Exactly.

We also use soluble fiber to stabilize stool form across all the subtypes.

And there's growing evidence for specific probiotic strains, like VSL -STEC3 and bifidobacterium infantis.

Oh, interesting.

What do they do?

They seem to actively modulate the local inflammatory response, and actually down -regulate those hypersensitive intestinal pain receptors.

And of course, for acute postprandial spasms, antispasmodic drugs like dicyclamine can be very effective.

Okay, now let's contrast that functional misfiring with celiac disease.

Because patients often confuse the two since the symptoms really overlap.

But celiac isn't just a food sensitivity.

Not at all.

It is a T -cell -mediated autoimmune destruction of the intestinal villi, specifically triggered by ingesting gluten.

And it has a massive genetic component, strongly linked to the HLA -DQ2 and HLA -DQ8 surface antigens.

The pathophysiology there is fascinating.

When a patient with celiac digests gluten, an enzyme called tissue transglutaminase modifies a specific gluten protein called gliadin.

And this modified gliadin perfectly binds to those HLA -DQ2 and DQ8 receptors on antigen -presenting cells.

That activates a massive T -cell inflammatory response that physically flattens the intestinal villi.

So if I'm in the clinic, how do I differentiate celiac from someone who just has, say, IBS with diarrhea?

You look for the systemic consequences of malabsorption.

Because celiac literally destroys the absorptive surface area of the small intestine, these patients don't just have diarrhea.

What else are we looking for?

They have profound iron deficiency anemia, severe fatigue, osteoporosis from calcium malabsorption, and weight loss.

Also, a small percentage present with a highly specific intensely itchy blistering skin rash called dermatitis herpetiformis.

Dermatitis herpetiformis, good to know.

And for diagnostics, we start with serology, checking for anti -TTG IgA antibodies.

But the absolute gold standard confirmation is an EGD with a duodenal biopsy to visually confirm that villis atrophy.

And the treatment is straightforward but incredibly difficult.

A strict lifelong gluten -free diet.

Exactly.

So building on that concept of disruptive flow and malabsorption, let's transition to conditions where the normal flow of chyme is physically halted or diverted into dead -end pouches, bowel obstructions, and diverticular disease.

A bowel obstruction is a literal blockade.

It can be a mechanical roadblock like a tumor, a stricture, or scar tissue adhesions from a prior surgery.

Or it can be functional, like a paralytic ileus where the parasolsus just stops.

And the physiological cascade of a complete obstruction is severe.

Proximal to the blockage, gas and fluid aggressively sequester.

The bowel distends massively, stops absorbing water, and actually starts actively secreting more fluid into the lumen.

That sounds disastrous.

It is.

Within 24 hours, a patient can lose up to the 8 liters of fluid directly into their gut.

This leads to profound vomiting,

severe hypovolemia, and eventually the pressure in the bowel wall exceeds arterial capillary pressure, leading to ischemia, necrosis, and peritonitis.

And this leads to one of my absolute favorite clinical aha moments.

Depending on where the obstruction is, it completely alters the patient's acid -base balance.

If it's a high early obstruction in the upper GI tract, the patient throws up massive amounts of gastric hydrochloric acid.

Losing that acid pushes them into metabolic alkalosis.

But if it's a lower late obstruction in the large bowel, they are losing highly alkaline fluids like pancreatic, bicarbonate, and bile.

Losing that base pushes them into metabolic acidosis.

It's a perfect example of physiology driving clinical presentation.

On assessment, you'll see a sudden onset of severe colicky abdominal pain.

Initially, if you listen, you'll hear high -pitched, hyperactive, rushing bowel sounds as the gut tries to force fluid past the blockade.

And on imaging.

The diagnostic hallmark is an upright abdominal x -ray.

You will see a ladder -like distension of the small bowel with multiple distinct air fluid levels.

Management has to be aggressive.

Make the patient MPO, insert an NG tube for immediate decompression, start heavy IV fluid resuscitation, and get an immediate surgical consult.

Okay, so that's a complete blockage.

But what about when the bowel isn't blocked, but the structural integrity of the wall itself gives way?

I'm talking about diverticular disease.

Diverticula are small, pouch -like protrusions of the mucosal layer pushing through the muscular wall, almost always in the descending and sigmoid colon.

Just having the pouches is diverticulosis.

Exactly.

But if a piece of undigested food or bacteria gets stuck in a pouch, forming a hardened mass called a faecolith, the pouch becomes inflamed and infected.

That is diverticulitis.

And because it predominantly affects the descending and sigmoid colon, the classic presentation of acute diverticulitis is localized left lower quadrant LOQ pain, often accompanied by a fever and a mild leukocytosis.

Right.

Now listen closely because this is a massive safety consideration for you.

You must never order a colonoscopy or a barium enema during an acute attack of diverticulitis.

That makes total sense because you've got an inflamed, thinned -out mucosal pouch that's already threatening to burst.

If you pump air or thick barium into the colon for a scope or an x -ray, you could easily blow out that pouch and cause a massive perforation, literally dumping feces straight into the peritoneum.

Precisely.

It's incredibly dangerous.

The safest and most effective imaging modality is a CT scan of the abdomen and pelvis with oral and IV contrast.

It will clearly show the bowel wall thickening and any abscess formation.

And from management, I feel like we used to just throw heavy antibiotics at every case.

We did, but the guidelines have shifted significantly.

The American Gastroenterological Association now advises against routine antibiotic use for mild, uncomplicated diverticulitis.

Really?

Why?

Because they recognize that it's often more of a localized inflammatory process than a systemic infection.

If they do have systemic signs or an abscess, amoxicillin and clagulinate is a common choice.

But the key is what happens after the acute phase resolves.

Right.

Prevention.

Exactly.

That's when you transition them to a high -fiber diet to keep stool bulky and moving, which reduces the intracolonic pressure that causes the diverticula in the first place.

Wow.

Okay.

We're entering our final physiological space.

We've covered acid erosion, structural failures, functional misfires, and physical blockages.

Now, what happens when inflammation in the bowel becomes chronic, systemic, and eventually leads to malignant cellular changes?

We need to tackle inflammatory bowel disease, IBD, and colorectal cancer.

IBD is an umbrella term for chronic relapsing immunological diseases,

primarily ulcerative colitis, or UC, and Crohn's disease.

It's crucial to understand how they differ in presentation because the underlying pathophysiology is very distinct.

Let's break it down by location and depth.

With ulcerative colitis, the disease is confined entirely to the colon and the rectum.

It always starts at the rectum and moves continuously upward.

Crohn's disease, on the other hand, can strike anywhere from the mouth to the anus.

But it's notorious for skip lesions areas of severe inflammation, separated by totally healthy normal tissue.

Then look at the depth of the inflammation.

UC is superficial.

It involves only the innermost mucosal layer.

But that mucosal layer becomes incredibly friable, meaning it bleeds at the slightest touch and it forms broad, shallow ulcers.

Which explains the symptoms.

Exactly.

That's why the absolute hallmark symptom of UC is frequent bloody diarrhea with mucus.

Crohn's is completely different.

The inflammation is transmural, meaning it cuts through the entire thickness of the bowel wall.

This deep penetrating inflammation causes a characteristic cobblestone appearance on endoscopy.

Yeah.

And because it goes all the way through the wall, Crohn's patients are highly prone to developing strictures from scar tissue and fistulas, which are abnormal tunnels connecting the bowels to the bladder, the vagina, or the skin.

And we should briefly mention microscopic colitis, which includes collagenous and lymphocytic variants.

In these patients, the colonoscopy looks completely normal to the naked eye.

The inflammation is only visible on a biopsy.

Oh, wow.

It presents as chronic, watery, non -bloody diarrhea and is heavily associated with chronic NSAID or PPI use.

For IBD, our management goal isn't just making the patient feel better.

The therapeutic target is actual mucosal healing.

We follow a step -up approach.

For mild UC, we start with five ASA agents like mesalamine, which act as local anti -inflammatories in the gut.

Right.

For acute flares, we step up to systemic corticosteroids.

And for moderate to severe disease, we rely on immunomodulators or biologics.

Drugs like infliximab, which specifically target and bind up TNF -alpha, a primary inflammatory cytokine.

Before we leave IBD, I really want to highlight a critical safety warning for your clinical practice.

If a patient is having a severe acute flare of ulcerative colitis, you must not give them antidiarrheal medications like lopramide.

Because stopping the motility just traps all that inflammation and gas inside an already weakened colon.

Exactly.

Using antidiarrheals during severe UC can precipitate toxic megacolon.

The colon becomes atonic, paralyzes, and massively distends to greater than six centimeters.

It is a surgical emergency with an extremely high risk of perforation and lethal sepsis.

That is a huge red flag.

From chronic inflammation, we take our final sobering step to malignancy.

Colorectal cancer.

It's the third most common cancer in the US.

Yeah.

The pathophysiology here is generally a slow, predictable evolution.

It starts as an adenomatous polyp, which is just a benign overgrowth of tissue.

But over the course of about 10 years, that polyp can grow, undergo cellular dysplasia, and mutate into an invasive adenocarcinoma.

And we use the TNM staging system conceptually to track this invasion.

TIS means carcinoma in situ, the cancer cells, are confined to the topmost epithelial layer.

By stage one, it has invaded the submucosa.

That spreads from there.

Right.

By stage three, the cancer is broken out and spread to the regional lymph nodes.

And stage four indicates distant metastasis.

Because of how the venous blood from the GI tract drains through the portal vein, colorectal cancer almost always metastasizes to the liver first.

And how the patient initially presents really depends on where the tumor decides to grow.

The right side of the colon is wider, and the stool is still mostly liquid.

So a right -sided tumor rarely causes an obstruction.

Instead, it acts like a slow, silent bleeder.

These patients usually present with occult blood in the stool, and unexplained iron deficiency anemia.

You might just notice they look pale and feel unusually fatigued.

But if the tumor is on the left side in the descending colon or rectum, the lumen is narrower, and the stool is solid.

These tumors frequently cause partial or complete obstructions.

So the symptoms are much more obvious.

Yes.

Patients will report colicky abdominal pain and a very distinct change in stool caliber.

They often describe ribbon -like or pencil -thin stools, because the solid feces is literally being squeezed past the tumor mass.

Because this specific cancer has such a long, slow evolution from polyp to adenocarcinoma, it is incredibly preventable if we catch the polyps early.

Screening is everything.

It really is.

The American Cancer Society guidelines now recommend that screening starts at age 55 for individuals at average risk.

The gold standard is a full colonoscopy every 10 years, or an annual fecal immunochemical test, a FIFIT test, which looks for hidden blood.

And if they have a first -degree relative with colon cancer, that baseline risk doubles or triples.

For them, screening needs to start at age 40, or 10 years before the age their relative was diagnosed, whichever comes first.

Okay, so let's take a breath and recap this incredible journey.

We started at the top with acid burning the esophageal squamous cells in GRD and the timing of PPI activation.

We moved down to the mechanical pressure bulging out hernias and internal hemorrhoids.

We explored the functional misfiring of the gut -brain axis in IBS and the T -cell -mediated autoimmune destruction in celiac disease.

We covered a lot of ground.

We really did.

We diagnosed the ladder -like fluid blockages of bowel obstructions and the acid -based shifts they cause.

We looked at the dangerous inflamed pouches of diverticulitis, the bloody mucosal burn of ulcerative colitis, and finally the slow cellular mutation of colorectal cancer.

It's an intricate,

profoundly interconnected system.

And if I can leave you with one final provocative thought as you continue your clinical training, keep your eye on the evolving science of the gut microbiome.

Oh, absolutely.

We briefly touched on how lower microbial variety is seen in IBS and how commensal microflora trigger the inflammatory cascade in IBD.

This internal landscape of trillions of bacteria is rapidly becoming the missing link in gastroenterology.

Understanding how the microbiome actively modulates our mucosal immunity is going to completely redefine targeted, personalized GI therapies in your clinical lifetime.

That is an amazing thought to end on.

A huge thank you for joining us for this deep dive.

On behalf of the Last Minute Lecture team, we wish you the absolute best of luck in your clinical rotations and on your upcoming exams.

Remember that perfectly engineered chemical processing plant we talked about at the beginning.

Just keep learning the mechanisms behind its sensors and you'll know exactly how to fix the valves.

Keep studying and we'll catch you next time.